Real-world evidence confirms high effectiveness of pfizer-biontech covid-19 vaccine and profound public health impact of vaccination one year after pandemic declared

Jerusalem, new york and mainz, germany, march 11, 2021 -  the israel ministry of health (moh), pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) today announced real-world evidence demonstrating dramatically lower incidence rates of covid-19 disease in individuals fully vaccinated with the pfizer-biontech covid-19 vaccine (bnt162b2), underscoring the observed substantial public health impact of israel's nationwide immunization program. these new data build upon and confirm previously released data from the moh demonstrating the vaccine's effectiveness in preventing symptomatic sars-cov-2 infections, covid-19 cases, hospitalizations, severe and critical hospitalizations, and deaths. the latest analysis from the moh proves that two weeks after the second vaccine dose protection is even stronger – vaccine effectiveness was at least 97% in preventing symptomatic disease, severe/critical disease and death. this comprehensive real-world evidence can be of importance to countries around the world as they advance their own vaccination campaigns one year after the world health organization (who) declared covid-19 a pandemic.
BNTX Ratings Summary
BNTX Quant Ranking